Doximity, Inc.

NYSE:DOCS

58.75 (USD) • At close February 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Revenue 136.832126.676118.057135.284113.612108.469110.966115.262102.18590.63993.65397.87679.3572.66966.68758.70945.11336.38836.35432.426
Cost of Revenue 13.67613.5512.56712.1912.75913.15313.67713.52613.2113.07711.76511.0858.9517.9867.9937.8727.4567.8754.2813.78
Gross Profit 123.156113.126105.49123.094100.85395.31697.289101.73688.97577.56281.88886.79170.39964.68358.69450.83737.65728.51332.07328.646
Gross Profit Ratio 0.90.8930.8940.910.8880.8790.8770.8830.8710.8560.8740.8870.8870.890.880.8660.8350.7840.8820.883
Reseach & Development Expenses 23.2422.57420.14819.94619.95821.93121.54120.51919.10419.02217.42416.22515.4613.24112.55811.4069.86610.0438.8918.605
General & Administrative Expenses 10.1039.2559.9739.6418.9669.2479.7599.5138.7498.72410.6449.0798.8277.1965.7034.4783.2093.1021.7681.954
Selling & Marketing Expenses 34.36735.24433.51734.95630.20134.45533.14833.2229.02128.13425.89925.69821.16119.37117.58617.01714.14513.28510.35210.669
SG&A 44.4744.29743.4944.59739.16743.70242.90742.73337.7736.85836.54334.77729.98826.56723.28921.49517.35416.38712.1212.623
Other Expenses 2.304-0.0520.073-0.0555.9034.8393.8752.4610.9080.804-0.0160.02-0.02-0.031-0.2634.601-0.093-0.2900
Operating Expenses 70.01466.87163.63864.54359.12565.63364.44863.25256.87455.8853.96751.00245.44839.80835.84732.90127.2226.4322.21721.265
Operating Income 53.14246.25541.85258.55133.79229.68332.84138.48432.10121.68227.92135.78924.95124.87522.84717.93610.4372.08311.0627.418
Operating Income Ratio 0.3880.3650.3550.4330.2970.2740.2960.3340.3140.2390.2980.3660.3140.3420.3430.3060.2310.0570.3040.229
Total Other Income Expenses Net 9.0297.1166.1014.4815.9034.8393.8752.4610.9080.804-0.0160.020.420.0450.0384.601-0.02-0.153-0.8860.325
Income Before Tax 62.17153.16947.95363.03239.69534.52236.71640.94533.00922.48627.90535.80925.37124.9222.88522.53710.4171.9310.1767.743
Income Before Tax Ratio 0.4540.420.4060.4660.3490.3180.3310.3550.3230.2480.2980.3660.320.3430.3430.3840.2310.0530.280.239
Income Tax Expense 18.01711.7927.33515.0769.0936.1166.0487.4776.710.103-8.821-19.838-10.717-1.4021.4025.3060.380.4712.7071.84
Net Income 44.15441.37740.61847.95630.60228.40630.66833.46826.29922.38336.72655.64736.08826.32221.48317.23110.0371.4593.5145.903
Net Income Ratio 0.3230.3270.3440.3540.2690.2620.2760.290.2570.2470.3920.5690.4550.3620.3220.2930.2220.040.0970.182
EPS 0.240.220.220.260.160.150.160.170.120.120.170.30.190.120.250.0360.0110.010.0450.072
EPS Diluted 0.220.210.20.240.150.130.140.160.120.10.170.260.170.090.190.0320.010.010.0430.072
EBITDA 58.05948.81744.461.0644.33229.68339.96138.48432.10121.68229.57535.78924.95124.87524.29718.45111.3652.85111.3647.617
EBITDA Ratio 0.4240.3850.3760.4530.460.2980.320.3570.3390.2650.3130.380.3290.3580.3570.3230.2520.0780.3130.235